T-lymphoblastic Lymphoma

• CLINICAL_TRIALS trial_result · 2026-02-25
  Clinical Trial Update: Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

  Phase 1/2 trial evaluating the combination of venetoclax and vincristine in adults with relapsed or refractory B- or T-cell acute lymphoblas…

• CLINICAL_TRIALS trial_result · 2024-11-21
  Clinical Trial Update: Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) [EARLY_Phase 1]

  This early-phase (Phase 1) clinical trial update reports completion of a study evaluating CD7-targeted CAR-T cell therapy in patients with r…

• CLINICAL_TRIALS trial_result · 2024-10-09
  Clinical Trial Update: Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma [EARLY_Phase 1]

  An early-phase 1 clinical trial is evaluating CD5-targeted CAR-T cells for relapsed/refractory CD5-positive T-lymphoblastic lymphoma and is …

• CLINICAL_TRIALS trial_result · 2023-06-28
  Clinical Trial Update: Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia [Phase 2]

  Phase 2 clinical trial update for venetoclax combined with IM2 in relapsed/refractory T lymphoblastic lymphoma/leukemia.

• CLINICAL_TRIALS trial_result · 2023-06-18
  Clinical Trial Update: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma [Phase 2]

  A Phase 2 clinical trial evaluating the modified BFM-95 regimen as first-line chemotherapy in adults with T-lymphoblastic lymphoma is ongoin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-03-20
  Clinical Trial Update: Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath [Phase 2]

  Phase 2 trial update investigating MabCampath for relapsed T-cell acute lymphoblastic leukemia or T-lymphoblastic lymphoma.

• CLINICAL_TRIALS trial_result · 2023-02-27
  Clinical Trial Update: Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma [Phase 2]

  Phase 2 clinical study of anti-CD1a CAR-T for relapsed/refractory acute T-lymphoblastic leukemia and lymphoblastic lymphoma is ongoing with …

• CLINICAL_TRIALS trial_result · 2018-09-14
  Clinical Trial Update: A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma [Phase 4]

  A Phase 4 clinical trial evaluating decitabine in relapsed or refractory T-lymphoblastic lymphoma is ongoing; current status is unknown.

• CLINICAL_TRIALS trial_result · 2010-08-23
  Clinical Trial Update: German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults [Phase 4]

  The document reports the completion of a German multicenter Phase 4 trial evaluating treatment for newly diagnosed T-lymphoblastic lymphoma …